Telangana Pharmatech is a specialty pharmaceutical company engaged in the drug development, manufacture and commercialization of pharmaceutical products. The company is floated by eminent professionals with vast experience in production, Research and Development, Quality Assurance and marketing of Intermediates of API's in India and abroad.
Telangana Pharmatech is founded by Dr. D.Sreedhar, PhD in organic chemistry and associated as senior scientist in Expicor Pharma Ltd , Hyderabad, Hetero Drugs , Hyderabad & Daelim Chemicals Pvt Ltd, South Korea.
Dr. D.Sreedhar to his credit has rich experiences of more then a decade in R&D and another decade in academics . He is a very good visioner, forecasting, planning and executing the ideas perfectly to take final accurate shape. He is dynamic in nature and always thinks for the well being of the society around him. With an idea of serving the society Dr. D. Sreedhar gave up a lucrative career with reputed firms and started Telangana Pharmatech.
Dr. D.Sreedhar participated in various international Symposia and seminars held in India and other countries like Germany, Spain, Korea etc. So many scientific research papers are published under the name of Dr.Sreedhar
We offer a broad range of analytical services for complex research needs. We perform method development, validate and transfer Good Manufacturing Practice
Telangana Pharmatech has an integrated approach towards the Custom Research and Manufacturing Services (CRAMS) offering products and services to the global life sciences industry...
At Telangana Pharmatech we believe in collaborating with a diverse set of partners. We value working with partners who are innovative, bold and enthusiastic about collaborating with...
Telangana Pharmatech has expertise in developing new products and processes that have world-class quality. Telangana Pharmatech is doing Research in various areas with special emphasis on...
Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore